nav



Antigen Express is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs.

» read more about us




6/1/2009   Generex Presents Positive Results of Phase 1 Prostate Cancer Vaccine Trial at the American Society of Clinical Oncology
 
5/28/2009   Generex Scientist to Participate in Panel Discussion at Swine Influenza Symposium
 
5/26/2009   Generex Biotechnology Presents Platform Vaccine Technology At International Congress of Antibodies
 
© 2004 Antigen Express | One Innovation Drive | Worcester, MA 01605
Phone: (508) 852-8783 | Fax: (508) 852 8653 | admin@antigenexpress.com
Website designed by NRG Networks